Argent Biopharma LtdASX: RGT

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Argent Biopharma Ltd via ASX

Filed with ASX ·

23 October 2026 September 2026 Quarterly Activity Report and Cash Flow Statement Argent Biopharma Ltd (ASX: RGT) is pleased to update the market for the September 2026 quarter, including material developments up to the date of this report, and attaches its Appendix 4C Quarterly Cash Flow report for...

View Attachment

6ix is reading this filing.

Argent Biopharma Ltd on 6ix

Story so far

Earlier from Argent Biopharma

All Argent Biopharma news releases